Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Pulmonary Embolism × edoxaban × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 2 Neoplasms 2 Venous Thromboembolism 1 Thrombosis 1 Pulmonary Embolism 1

Interventions

apixaban 2 Rivaroxaban 2 Enoxaparin 2 enoxaparin sodium 1 edoxaban 1 Warfarin 1 Tinzaparin 1 Hospitals 1 Heparin, Low-Molecular-Weight 1 Fondaparinux 1 Educational Status 1 Dalteparin 1 Dabigatran 1 4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed

811 enrolled 19 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡